Last month marked Women’s History Month, and in February there was International Day of Women and Girls in Science, too. But, ...
Oligonucleotide (oligo) therapies have been in development for decades. Recent advances in molecular design, chemistry, ...
In addition to the three NPVs, the FDA also announced the approval of an IND submission for DemeRx, which is investigating ...
The regulator has sent a complete response letter (CRL) to AbbVie for trenibotulinumtoxinE (TrenibotE), a follow-up to its ...
Sanofi's new chief executive, Belén Garijo, will see her tenure at the company kick-started by a strong 2026 first quarter, ...
In biotech, value is created at discrete moments – when data resolves uncertainty. Until then, risk remains. Every dollar ...
Clinical trial sponsors and contract research organisations (CROs) are expanding clinical trials internationally to access ...
Regeneron has become the first company to get US approval for a gene therapy for congenital hearing loss, after the FDA gave ...
The Telethon Undiagnosed Diseases Programme (TUDP), run by the Naples-based biomedical charity Fondazione Telethon, has ...
The phase 3 LITESPARK-012 trial is testing triplet therapy with oral HIF-2 alpha inhibitor Welireg (belzutifan) given ...
The trio of positive studies means that AZ is in pole position to bring an anti-IL-33 drug to market for COPD, after some ...
Roche could be just months away from an FDA approval of Gazyva as the first anti-CD20 therapy for systemic lupus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results